Skip to content

Rapid Micro Biosystems RPID Additional Paid-In Capital

Additional Paid-In Capital at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.97B-0.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$490.5M+3.1%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$2.71B+1.5%
iRadimed logo
iRadimedIRMD
$31.02M+0.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$6.67B+1.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$0-100%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's additional paid-in capital?
Rapid Micro Biosystems (RPID) reported additional paid-in capital of $556.61M in Q1 2026.
How has Rapid Micro Biosystems's additional paid-in capital changed year-over-year?
Rapid Micro Biosystems's additional paid-in capital increased by 0.9% year-over-year, from $551.58M to $556.61M.
What is the long-term trend for Rapid Micro Biosystems's additional paid-in capital?
Over 5 years (2020 to 2025), Rapid Micro Biosystems's additional paid-in capital has grown at a 37.1% compound annual growth rate (CAGR), from $114.58M to $555.15M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.